296 related articles for article (PubMed ID: 4596251)
1. [Controlled clinical experimentation of a new synthetic preparation (MY 41-6) with anti-inflammatory, antalgic and myorelaxant effect].
Capretti G; Marinoni C
Clin Ter; 1974 Feb; 68(3):233-45. PubMed ID: 4596251
[No Abstract] [Full Text] [Related]
2. [Clinical study of a new drug combination in rheumatology].
Buoniconti A; Ruiz SI; D'Auria H; Cobra CJ
Hospital (Rio J); 1965 Apr; 67(4):783-8. PubMed ID: 5294228
[No Abstract] [Full Text] [Related]
3. [Effect of perclusone in rheumatic diseases].
Amatuni H
Reumatologia; 1973 Jan; 11(1):37-42. PubMed ID: 4540529
[No Abstract] [Full Text] [Related]
4. [Treatment of degenerative and inflammatory joint diseases with or without a new synthetic substance (parsalmide). Controlled clinical trial].
Napoli A; Alderuccio B; Nannetti A
Clin Ter; 1977 Dec; 83(5):541-7. PubMed ID: 343972
[No Abstract] [Full Text] [Related]
5. [Parsalmide, a new synthetic substance, in inflammatory and arthrosic arthropathies. Double-blind controlled clinical trial].
Menci S; Rossi M; Del Curatolo G; Orsucci PL
Minerva Med; 1976 Oct; 67(52):3403-8. PubMed ID: 792740
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of degenerative rheumatic diseases. Therapy of painful irritation-conditions of the spine and of periarthrosis using a new combination preparation].
Gerhold H
Fortschr Med; 1974 Aug; 92(22):958-61. PubMed ID: 4547109
[No Abstract] [Full Text] [Related]
7. [Percluson (Clophezon)--clinical drug evaluation].
Wysocka K; Szwed L
Pol Tyg Lek; 1973 Nov; 28(48):1902-3. PubMed ID: 4543746
[No Abstract] [Full Text] [Related]
8. [Propaxoline citrate. Its use in various inflammatory-spastic syndromes of the urogenital system].
Trucchi E
Minerva Urol; 1970; 22(2):49-54. PubMed ID: 4919676
[No Abstract] [Full Text] [Related]
9. [Comparison of the effects of phenylbutazone and a combination preparation (Exrheudon) in rheumatic diseases].
Engel P
MMW Munch Med Wochenschr; 1977 Jan; 119(3):93-4. PubMed ID: 403430
[No Abstract] [Full Text] [Related]
10. [On clinical evaluation of the effect of azapropazon, a new anti-inflammatory agent, in diseases of the rheumatic group].
Beckschäfer W
Arzneimittelforschung; 1969 Jan; 19(1):52-3. PubMed ID: 4182977
[No Abstract] [Full Text] [Related]
11. [Clinical trial of a new anti-inflammatory agent in rheumatology, ANP 3260 or clofezone].
Verhaeghe A; Lesage R; Delcambre B
Lille Med; 1968 Mar; 13(3):Suppl:260-5. PubMed ID: 4927184
[No Abstract] [Full Text] [Related]
12. [Controlled clinical trial of parsalmide, a drug with analgesic and anti-inflammatory activity].
Tafner G; Pedrazzoli M; Bajocchi E
Minerva Med; 1976 Oct; 67(52):3383-90. PubMed ID: 792737
[TBL] [Abstract][Full Text] [Related]
13. [Meprotixol (N 7020). Clinical experiences in rheumatic diseases].
Kogstad O
Tidsskr Nor Laegeforen; 1974 Feb; 94(4):212-4. PubMed ID: 4595469
[No Abstract] [Full Text] [Related]
14. ["Double-blind" clinical study of a non-steroid anti-inflammatory drug: glucametacine].
Pipino F; Franchin F
Minerva Med; 1980 Oct; 71(39):2845-50. PubMed ID: 7001282
[TBL] [Abstract][Full Text] [Related]
15. [Clinical trial of Midalgyl in rheumatology].
Verhaeghe A; Delcambre B
Lille Med; 1971 Apr; 16():S 2:638-9. PubMed ID: 5317348
[No Abstract] [Full Text] [Related]
16. [Value of pyrazinobutazone in the treatment of different inflammatory states].
Gaillarde B; Ortonne JP; Pugeat M; Plauchu M
J Med Lyon; 1972 Oct; 53(234):1315-6 passim. PubMed ID: 4539046
[No Abstract] [Full Text] [Related]
17. [Pyrasanone in the treatment of rheumatism].
Pellegrini P; Colamussi V; Trotta F; Scaramelli M; Bazzanini G
Minerva Med; 1975 Oct; 66(67):3509-33. PubMed ID: 1103007
[TBL] [Abstract][Full Text] [Related]
18. [Possibilities and therapeutic limits of a biological preparation in arthro-neuralgias based on arthrosis].
Monteleone M
Clin Ortop; 1973; 24(3):194-201. PubMed ID: 4619063
[No Abstract] [Full Text] [Related]
19. [Midalgyl in rheumatology. Study on 50 patients].
Laborie G
Bord Med; 1971 Sep; 4(9):2471-2 passim. PubMed ID: 5315933
[No Abstract] [Full Text] [Related]
20. [Meprotixol (N 7020). Studied in rheumatic diseases in a double blind multicenter investigation in general practice].
Kogstad O; Apall-Olsen P; Fjerdingstad S; Garfelt R; Helgesen RO; Joheim I; Klaastad R; Rosenberg I; Selvåg J; Toreid K; Tonnessen JS
Tidsskr Nor Laegeforen; 1974 Feb; 94(4):209-12. PubMed ID: 4595468
[No Abstract] [Full Text] [Related]
[Next] [New Search]
